Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 183

    1.

    Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study.

    Sattar N, Scherbakova O, Ford I, O'Reilly DS, Stanley A, Forrest E, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J; west of Scotland coronary prevention study.

    Diabetes. 2004 Nov;53(11):2855-60.PMID: 15504965 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study.

    Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J.

    Circulation. 2003 Jul 29;108(4):414-9. Epub 2003 Jul 14.PMID: 12860911 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Serum alanine aminotransferase is associated with serum adiponectin, C-reactive protein and apolipoprotein B in young healthy men.

    Kazumi T, Kawaguchi A, Hirano T, Yoshino G.

    Horm Metab Res. 2006 Feb;38(2):119-24.PMID: 16523413 [PubMed - indexed for MEDLINE]Related articles

    4.

    Prediction of coronary atherosclerotic disease with liver transaminase level.

    Adibi P, Sadeghi M, Mahsa M, Rozati G, Mohseni M.

    Liver Int. 2007 Sep;27(7):895-900.PMID: 17696927 [PubMed - indexed for MEDLINE]Related articles

    5.

    C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study.

    Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N; West of Scotland Coronary Prevention Study.

    Diabetes. 2002 May;51(5):1596-600.PMID: 11978661 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men.

    Wannamethee SG, Shaper AG, Lennon L, Whincup PH.

    Diabetes Care. 2005 Dec;28(12):2913-8.PMID: 16306554 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor.

    Sattar N, McConnachie A, Ford I, Gaw A, Cleland SJ, Forouhi NG, McFarlane P, Shepherd J, Cobbe S, Packard C.

    Diabetes. 2007 Apr;56(4):984-91.PMID: 17395744 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study.

    Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Kempf J, Zinman B, Haffner SM; insulin resistance atherosclerosis study.

    Diabetes. 2004 Oct;53(10):2623-32.PMID: 15448093 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver.

    Kim CH, Park JY, Lee KU, Kim JH, Kim HK.

    Diabetes Metab Res Rev. 2009 Jan;25(1):64-9.PMID: 19065605 [PubMed - indexed for MEDLINE]Related articles

    10.

    Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study.

    Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Haffner SM.

    Diabetes. 2005 Nov;54(11):3140-7.PMID: 16249437 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.

    Oh SY, Cho YK, Kang MS, Yoo TW, Park JH, Kim HJ, Park DI, Sohn CI, Jeon WK, Kim BI, Son BH, Shin JH.

    Metabolism. 2006 Dec;55(12):1604-9.PMID: 17142131 [PubMed - indexed for MEDLINE]Related articles

    12.

    Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men.

    Nakanishi N, Suzuki K, Tatara K.

    Diabetes Care. 2004 Jun;27(6):1427-32.PMID: 15161799 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes.

    Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT; PREVEND Study Group.

    Diabetes Care. 2005 Oct;28(10):2525-30.PMID: 16186291 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998.

    Thorand B, Löwel H, Schneider A, Kolb H, Meisinger C, Fröhlich M, Koenig W.

    Arch Intern Med. 2003 Jan 13;163(1):93-9.PMID: 12523922 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndrome.

    Forlani G, Di Bonito P, Mannucci E, Capaldo B, Genovese S, Orrasch M, Scaldaferri L, Di Bartolo P, Melandri P, Dei Cas A, Zavaroni I, Marchesini G.

    J Endocrinol Invest. 2008 Feb;31(2):146-52.PMID: 18362506 [PubMed - indexed for MEDLINE]Related articles

    16.

    Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein.

    Malik S, Wong ND, Franklin S, Pio J, Fairchild C, Chen R.

    Diabetes Care. 2005 Mar;28(3):690-3.PMID: 15735209 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Alanine aminotransferase and high sensitivity C-reactive protein: correlates of cardiovascular risk factors in youth.

    Oliveira AC, Oliveira AM, Almeida MS, Silva AM, Adan L, Ladeia AM.

    J Pediatr. 2008 Mar;152(3):337-42. Epub 2007 Oct 22.PMID: 18280837 [PubMed - indexed for MEDLINE]Related articles

    18.

    Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome.

    Kerner A, Avizohar O, Sella R, Bartha P, Zinder O, Markiewicz W, Levy Y, Brook GJ, Aronson D.

    Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):193-7. Epub 2004 Oct 21.PMID: 15499043 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes.

    Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE, Bogardus C, Tataranni PA.

    Diabetes. 2002 Jun;51(6):1889-95.PMID: 12031978 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study.

    Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM.

    Diabetes Care. 2002 Nov;25(11):2016-21.PMID: 12401749 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data